TRSO acquires 100% of AI TCM firm XRS for 10M restricted shares plus earnout

TRANSUITE.ORG INC.

TRSO issued 10M restricted shares to Hailiang Li for 100% of XRS; earnout may add shares based on 90-day valuation.
XRS combines AI social agents with Traditional Chinese Medicine; owns 300 proprietary TCM e-books and a 21-day health supervision system.
Acquisition closed Sept 30, 2025; TRSO expands into AI-powered healthcare and TCM sectors.
CEO Mengqing Fan says the deal will integrate AI and blockchain to globalize TCM products.
XRS CEO Hailiang Li expects TRSO's technology to enhance product intelligence and global expansion.

item 1.01item 2.01item 3.02item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.